In silico analyses of immune system protein interactome network, single-cell RNA sequencing of human tissues, and artificial neural networks reveal potential therapeutic targets for drug repurposing against COVID-19

Background: There is pressing urgency to identify therapeutic targets and drugs that allow treating COVID-19 patients effectively. Methods: We performed in silico analyses of immune system protein interactome network, single-cell RNA sequencing of human tissues, and artificial neural networks to rev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: López-Cortés, Andrés (VerfasserIn) , Guevara-Ramírez, Patricia (VerfasserIn) , Kyriakidis, Nikolaos C. (VerfasserIn) , Barba-Ostria, Carlos (VerfasserIn) , León Cáceres, Ángela (VerfasserIn) , Guerrero, Santiago (VerfasserIn) , Ortiz-Prado, Esteban (VerfasserIn) , Munteanu, Cristian R. (VerfasserIn) , Tejera, Eduardo (VerfasserIn) , Cevallos-Robalino, Doménica (VerfasserIn) , Gómez-Jaramillo, Ana María (VerfasserIn) , Simbaña-Rivera, Katherine (VerfasserIn) , Granizo-Martínez, Adriana (VerfasserIn) , Pérez-M, Gabriela (VerfasserIn) , Moreno, Silvana (VerfasserIn) , García-Cárdenas, Jennyfer M. (VerfasserIn) , Zambrano, Ana Karina (VerfasserIn) , Pérez-Castillo, Yunierkis (VerfasserIn) , Cabrera-Andrade, Alejandro (VerfasserIn) , Puig San Andrés, Lourdes (VerfasserIn) , Proaño-Castro, Carolina (VerfasserIn) , Bautista, Jhommara (VerfasserIn) , Quevedo, Andreina (VerfasserIn) , Varela, Nelson (VerfasserIn) , Quiñones, Luis Abel (VerfasserIn) , Paz-y-Miño, César (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 26 February 2021
In: Frontiers in pharmacology
Year: 2021, Jahrgang: 12, Pages: 1-24
ISSN:1663-9812
DOI:10.3389/fphar.2021.598925
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3389/fphar.2021.598925
Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/articles/10.3389/fphar.2021.598925/full
Volltext
Verfasserangaben:Andrés López-Cortés, Patricia Guevara-Ramírez, Nikolaos C. Kyriakidis, Carlos Barba-Ostria, Ángela León Cáceres, Santiago Guerrero, Esteban Ortiz-Prado, Cristian R. Munteanu, Eduardo Tejera, Doménica Cevallos-Robalino, Ana María Gómez-Jaramillo, Katherine Simbaña-Rivera, Adriana Granizo-Martínez, Gabriela Pérez-M, Silvana Moreno, Jennyfer M. García-Cárdenas, Ana Karina Zambrano, Yunierkis Pérez-Castillo, Alejandro Cabrera-Andrade, Lourdes Puig San Andrés, Carolina Proaño-Castro, Jhommara Bautista, Andreina Quevedo, Nelson Varela, Luis Abel Quiñones and César Paz-y-Miño

MARC

LEADER 00000caa a2200000 c 4500
001 1757668950
003 DE-627
005 20230428185528.0
007 cr uuu---uuuuu
008 210511s2021 xx |||||o 00| ||eng c
024 7 |a 10.3389/fphar.2021.598925  |2 doi 
035 |a (DE-627)1757668950 
035 |a (DE-599)KXP1757668950 
035 |a (OCoLC)1341408616 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a López-Cortés, Andrés  |e VerfasserIn  |0 (DE-588)1208014641  |0 (DE-627)1694305392  |4 aut 
245 1 0 |a In silico analyses of immune system protein interactome network, single-cell RNA sequencing of human tissues, and artificial neural networks reveal potential therapeutic targets for drug repurposing against COVID-19  |c Andrés López-Cortés, Patricia Guevara-Ramírez, Nikolaos C. Kyriakidis, Carlos Barba-Ostria, Ángela León Cáceres, Santiago Guerrero, Esteban Ortiz-Prado, Cristian R. Munteanu, Eduardo Tejera, Doménica Cevallos-Robalino, Ana María Gómez-Jaramillo, Katherine Simbaña-Rivera, Adriana Granizo-Martínez, Gabriela Pérez-M, Silvana Moreno, Jennyfer M. García-Cárdenas, Ana Karina Zambrano, Yunierkis Pérez-Castillo, Alejandro Cabrera-Andrade, Lourdes Puig San Andrés, Carolina Proaño-Castro, Jhommara Bautista, Andreina Quevedo, Nelson Varela, Luis Abel Quiñones and César Paz-y-Miño 
264 1 |c 26 February 2021 
300 |a 24 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 11.05.2021 
520 |a Background: There is pressing urgency to identify therapeutic targets and drugs that allow treating COVID-19 patients effectively. Methods: We performed in silico analyses of immune system protein interactome network, single-cell RNA sequencing of human tissues, and artificial neural networks to reveal potential therapeutic targets for drug repurposing against COVID-19. Results: We screened 1,584 high-confidence immune system proteins in ACE2 and TMPRSS2 co-expressing cells, finding 25 potential therapeutic targets significantly overexpressed in nasal goblet secretory cells, lung type II pneumocytes, and ileal absorptive enterocytes of patients with several immunopathologies. Then, we performed fully connected deep neural networks to find the best multitask classification model to predict the activity of 10,672 drugs, obtaining several approved drugs, compounds under investigation, and experimental compounds with the highest area under the receiver operating characteristics. Conclusion: After being effectively analyzed in clinical trials, these drugs can be considered for treatment of COVID-19 patients. Scripts can be downloaded at https://github.com/muntisa/immuno-drug-repurposing-COVID-19. 
650 4 |a artificial neural networks 
650 4 |a COVID-19 
650 4 |a drugs 
650 4 |a Immune System 
650 4 |a single-cell RNA sequencing 
700 1 |a Guevara-Ramírez, Patricia  |e VerfasserIn  |4 aut 
700 1 |a Kyriakidis, Nikolaos C.  |e VerfasserIn  |4 aut 
700 1 |a Barba-Ostria, Carlos  |e VerfasserIn  |4 aut 
700 1 |a León Cáceres, Ángela  |e VerfasserIn  |0 (DE-588)1212543416  |0 (DE-627)1702065715  |4 aut 
700 1 |a Guerrero, Santiago  |e VerfasserIn  |4 aut 
700 1 |a Ortiz-Prado, Esteban  |e VerfasserIn  |4 aut 
700 1 |a Munteanu, Cristian R.  |e VerfasserIn  |4 aut 
700 1 |a Tejera, Eduardo  |e VerfasserIn  |4 aut 
700 1 |a Cevallos-Robalino, Doménica  |e VerfasserIn  |4 aut 
700 1 |a Gómez-Jaramillo, Ana María  |e VerfasserIn  |4 aut 
700 1 |a Simbaña-Rivera, Katherine  |e VerfasserIn  |4 aut 
700 1 |a Granizo-Martínez, Adriana  |e VerfasserIn  |4 aut 
700 1 |a Pérez-M, Gabriela  |e VerfasserIn  |4 aut 
700 1 |a Moreno, Silvana  |e VerfasserIn  |4 aut 
700 1 |a García-Cárdenas, Jennyfer M.  |e VerfasserIn  |4 aut 
700 1 |a Zambrano, Ana Karina  |e VerfasserIn  |4 aut 
700 1 |a Pérez-Castillo, Yunierkis  |e VerfasserIn  |4 aut 
700 1 |a Cabrera-Andrade, Alejandro  |e VerfasserIn  |4 aut 
700 1 |a Puig San Andrés, Lourdes  |e VerfasserIn  |4 aut 
700 1 |a Proaño-Castro, Carolina  |e VerfasserIn  |4 aut 
700 1 |a Bautista, Jhommara  |e VerfasserIn  |4 aut 
700 1 |a Quevedo, Andreina  |e VerfasserIn  |4 aut 
700 1 |a Varela, Nelson  |e VerfasserIn  |4 aut 
700 1 |a Quiñones, Luis Abel  |e VerfasserIn  |4 aut 
700 1 |a Paz-y-Miño, César  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in pharmacology  |d Lausanne : Frontiers Media, 2010  |g 12(2021), Artikel-ID 598925, Seite 1-24  |h Online-Ressource  |w (DE-627)642889392  |w (DE-600)2587355-6  |w (DE-576)335527108  |x 1663-9812  |7 nnas  |a In silico analyses of immune system protein interactome network, single-cell RNA sequencing of human tissues, and artificial neural networks reveal potential therapeutic targets for drug repurposing against COVID-19 
773 1 8 |g volume:12  |g year:2021  |g elocationid:598925  |g pages:1-24  |g extent:24  |a In silico analyses of immune system protein interactome network, single-cell RNA sequencing of human tissues, and artificial neural networks reveal potential therapeutic targets for drug repurposing against COVID-19 
856 4 0 |u https://doi.org/10.3389/fphar.2021.598925  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/articles/10.3389/fphar.2021.598925/full  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210511 
993 |a Article 
994 |a 2021 
998 |g 1212543416  |a León Cáceres, Ángela  |m 1212543416:León Cáceres, Ángela  |p 5 
999 |a KXP-PPN1757668950  |e 3927544590 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1757668950","language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 11.05.2021"],"title":[{"title_sort":"In silico analyses of immune system protein interactome network, single-cell RNA sequencing of human tissues, and artificial neural networks reveal potential therapeutic targets for drug repurposing against COVID-19","title":"In silico analyses of immune system protein interactome network, single-cell RNA sequencing of human tissues, and artificial neural networks reveal potential therapeutic targets for drug repurposing against COVID-19"}],"person":[{"display":"López-Cortés, Andrés","roleDisplay":"VerfasserIn","role":"aut","family":"López-Cortés","given":"Andrés"},{"roleDisplay":"VerfasserIn","display":"Guevara-Ramírez, Patricia","role":"aut","family":"Guevara-Ramírez","given":"Patricia"},{"family":"Kyriakidis","given":"Nikolaos C.","display":"Kyriakidis, Nikolaos C.","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Barba-Ostria","given":"Carlos","display":"Barba-Ostria, Carlos","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"León Cáceres, Ángela","roleDisplay":"VerfasserIn","given":"Ángela","family":"León Cáceres"},{"roleDisplay":"VerfasserIn","display":"Guerrero, Santiago","role":"aut","family":"Guerrero","given":"Santiago"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Ortiz-Prado, Esteban","given":"Esteban","family":"Ortiz-Prado"},{"role":"aut","display":"Munteanu, Cristian R.","roleDisplay":"VerfasserIn","given":"Cristian R.","family":"Munteanu"},{"roleDisplay":"VerfasserIn","display":"Tejera, Eduardo","role":"aut","family":"Tejera","given":"Eduardo"},{"family":"Cevallos-Robalino","given":"Doménica","roleDisplay":"VerfasserIn","display":"Cevallos-Robalino, Doménica","role":"aut"},{"role":"aut","display":"Gómez-Jaramillo, Ana María","roleDisplay":"VerfasserIn","given":"Ana María","family":"Gómez-Jaramillo"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Simbaña-Rivera, Katherine","given":"Katherine","family":"Simbaña-Rivera"},{"family":"Granizo-Martínez","given":"Adriana","roleDisplay":"VerfasserIn","display":"Granizo-Martínez, Adriana","role":"aut"},{"given":"Gabriela","family":"Pérez-M","role":"aut","roleDisplay":"VerfasserIn","display":"Pérez-M, Gabriela"},{"roleDisplay":"VerfasserIn","display":"Moreno, Silvana","role":"aut","family":"Moreno","given":"Silvana"},{"roleDisplay":"VerfasserIn","display":"García-Cárdenas, Jennyfer M.","role":"aut","family":"García-Cárdenas","given":"Jennyfer M."},{"role":"aut","roleDisplay":"VerfasserIn","display":"Zambrano, Ana Karina","given":"Ana Karina","family":"Zambrano"},{"given":"Yunierkis","family":"Pérez-Castillo","role":"aut","display":"Pérez-Castillo, Yunierkis","roleDisplay":"VerfasserIn"},{"given":"Alejandro","family":"Cabrera-Andrade","role":"aut","roleDisplay":"VerfasserIn","display":"Cabrera-Andrade, Alejandro"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Puig San Andrés, Lourdes","given":"Lourdes","family":"Puig San Andrés"},{"family":"Proaño-Castro","given":"Carolina","roleDisplay":"VerfasserIn","display":"Proaño-Castro, Carolina","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Bautista, Jhommara","role":"aut","family":"Bautista","given":"Jhommara"},{"family":"Quevedo","given":"Andreina","display":"Quevedo, Andreina","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Varela, Nelson","roleDisplay":"VerfasserIn","role":"aut","family":"Varela","given":"Nelson"},{"given":"Luis Abel","family":"Quiñones","role":"aut","roleDisplay":"VerfasserIn","display":"Quiñones, Luis Abel"},{"role":"aut","display":"Paz-y-Miño, César","roleDisplay":"VerfasserIn","given":"César","family":"Paz-y-Miño"}],"relHost":[{"title":[{"title_sort":"Frontiers in pharmacology","title":"Frontiers in pharmacology"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"In silico analyses of immune system protein interactome network, single-cell RNA sequencing of human tissues, and artificial neural networks reveal potential therapeutic targets for drug repurposing against COVID-19Frontiers in pharmacology","note":["Gesehen am 08.09.20"],"language":["eng"],"recId":"642889392","pubHistory":["2010 -"],"part":{"volume":"12","text":"12(2021), Artikel-ID 598925, Seite 1-24","extent":"24","year":"2021","pages":"1-24"},"origin":[{"publisherPlace":"Lausanne","dateIssuedKey":"2010","publisher":"Frontiers Media","dateIssuedDisp":"2010-"}],"id":{"issn":["1663-9812"],"zdb":["2587355-6"],"eki":["642889392"]},"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"24 S."}],"id":{"doi":["10.3389/fphar.2021.598925"],"eki":["1757668950"]},"origin":[{"dateIssuedDisp":"26 February 2021","dateIssuedKey":"2021"}],"name":{"displayForm":["Andrés López-Cortés, Patricia Guevara-Ramírez, Nikolaos C. Kyriakidis, Carlos Barba-Ostria, Ángela León Cáceres, Santiago Guerrero, Esteban Ortiz-Prado, Cristian R. Munteanu, Eduardo Tejera, Doménica Cevallos-Robalino, Ana María Gómez-Jaramillo, Katherine Simbaña-Rivera, Adriana Granizo-Martínez, Gabriela Pérez-M, Silvana Moreno, Jennyfer M. García-Cárdenas, Ana Karina Zambrano, Yunierkis Pérez-Castillo, Alejandro Cabrera-Andrade, Lourdes Puig San Andrés, Carolina Proaño-Castro, Jhommara Bautista, Andreina Quevedo, Nelson Varela, Luis Abel Quiñones and César Paz-y-Miño"]}} 
SRT |a LOPEZCORTEINSILICOAN2620